Active pharmacotherapy versus expectant management of patent ductus arteriosus in extremely preterm infants: a meta-analysis with trial sequential analysis

医学 药物治疗 动脉导管 随机对照试验 妊娠期 怀孕 胎龄 临床试验 儿科 支气管肺发育不良 期待疗法 产科 死亡率 内科学 外科 心理干预 需要治疗的数量
作者
Shripada C. Rao,Chandra Rath,Sanjay Patole
出处
期刊:Archives of Disease in Childhood-fetal and Neonatal Edition [BMJ]
卷期号:: fetalneonatal-2026
标识
DOI:10.1136/archdischild-2026-331024
摘要

Objectives To assess the effectiveness and safety of active pharmacotherapy for patent ductus arteriosus (PDA) initiated based on echocardiography-criteria versus expectant management in extremely preterm infants <29 w gestation in the first three weeks of life. Study design Systematic review with meta-analysis and trial sequential analysis (TSA). We searched PubMed, Embase, CENTRAL and Emcare for randomised trials published between 2010 and May 2026. We synthesised results using random-effects meta-analysis and conducted a TSA. Patients Extremely preterm infants with PDA considered as significant on echocardiography. Interventions Pharmacotherapy versus expectant management. Main outcome measures Mortality by 36 weeks postconceptional age or before discharge and chronic lung disease (CLD). Results We included 12 trials involving 2344 extremely preterm infants. Meta-analysis found increased risk of mortality with active pharmacotherapy (RR 1.34, 95% CI 1.08 to 1.67; p=0.008, I 2 =0%; 12 randomised controlled trials (RCTs)). Number-needed-to-treat for an additional harmful outcome (i.e. mortality) was 25 (95% CI 17 to 100). On TSA conducted with the stringent alpha error 3.3% and beta 10%, the cumulative Z-score touched the O’Brien–Fleming monitoring boundary at the current sample size, supporting the meta-analysis findings under the specified TSA assumptions. For CLD, meta-analysis showed little or no difference (RR 0.99, 95% CI 0.92 to 1.06, p=0.74, I 2 =14%, 12 RCTs). The certainty of evidence was high for mortality and moderate for CLD. Conclusions In extremely preterm infants, active pharmacotherapy for PDA based on current echocardiographic criteria in the first three weeks of life was associated with increased mortality with a clinically important number needed to harm. These findings should inform treatment decisions and discussions with parents while ongoing research seeks to identify infants who may benefit from treatment. PROSPERO registration number CRD420261303992.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
雪山大地发布了新的文献求助10
刚刚
1秒前
喂喂喂完成签到 ,获得积分10
4秒前
Bismarck完成签到 ,获得积分10
4秒前
wanci的应助被酷酷的怀莲采纳,获得50
6秒前
活泼雪莲发布了新的文献求助10
7秒前
10秒前
爱而不得完成签到 ,获得积分10
10秒前
科研摆渡人完成签到,获得积分10
11秒前
laber完成签到,获得积分0
11秒前
wang完成签到 ,获得积分10
14秒前
xipding完成签到,获得积分10
14秒前
16秒前
huluwa完成签到,获得积分10
20秒前
yihao完成签到 ,获得积分10
21秒前
刘较瘦完成签到,获得积分10
23秒前
科研人完成签到,获得积分10
23秒前
雪山大地发布了新的文献求助10
23秒前
花火妖妖完成签到,获得积分10
28秒前
长孙烙完成签到 ,获得积分10
28秒前
江安弘完成签到,获得积分10
28秒前
hanliulaixi完成签到 ,获得积分10
29秒前
30秒前
文文武完成签到 ,获得积分10
30秒前
活泼红牛完成签到,获得积分10
32秒前
123完成签到,获得积分10
35秒前
菜鸟学习完成签到 ,获得积分10
38秒前
LA完成签到,获得积分10
40秒前
甜美尔烟完成签到,获得积分10
43秒前
Jaycee完成签到 ,获得积分10
43秒前
YMM完成签到,获得积分10
43秒前
SciGPT的应助被活泼雪莲采纳,获得10
47秒前
小叶完成签到 ,获得积分10
50秒前
雪山大地发布了新的文献求助10
50秒前
50秒前
Bi完成签到,获得积分10
51秒前
刘亦菲完成签到 ,获得积分10
52秒前
ldd完成签到,获得积分10
53秒前
lingling完成签到 ,获得积分10
54秒前
快乐香水完成签到 ,获得积分10
56秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Hidden Empire of Finance: How Wall Street Profits from Our Cities and Fuels Global Inequality 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8166550
求助须知:如何正确求助?哪些是违规求助? 9559535
关于积分的说明 21750720
捐赠科研通 7757357
什么是DOI,文献DOI怎么找? 3429141
关于科研通互助平台的介绍 2553523
邀请新用户注册赠送积分活动 2473904